|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
| City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
||||||||
| TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 1/20/2016 7:00:43 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 1695, HR 3020 - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
HR 1314 - Bipartisan Budget Act/Budget Control Act relief to end sequestration for non-defense discretionary spending: Funding for AAFP priorities; mitigating budget increases for medicare part B enrollees.
HR 2029 - Funding of primary care and quality research at Agency for Healthcare Research and Quality: Primary care research at AHRQ.
HR 3020 - Oppose House draft FY16 bill to eliminate AHRQ: Preserve primary care practice-based research, patient safety, HIT.
HR 3940 - Meaningful use 2 hardship relief: Prevent penalty on FPs who have not met MU2.
No Bill No.- HHS Budget planning for FY 16 & 17: Funding for AAFP Priorities
No Bill No.- Congressional Primary Care Caucus: Primary care to achieve triple aim in health care.
No Bill No. - National Advisory Council on National Health Service Care (NHSC): Primary care physician workforce and medical student debt relief.
No Bill No. - Congressional Public Health Caucus Briefing: AAFP federal spending priorities.
No Bill No. - National Coalition on Health Care forum on Advanced Medical Home: primary care practice model.
No Bill No. - Attend weekly legislative strategy meetings: Support of Legislative efforts to advance primary care policies through insurance reform, public health, graduate medical education and regulatory flexibility.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Agency for Healthcare Research & Quality (AHRQ), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 1695, HR 3020, HR 2029 - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
S. 1719 - Recognize, Assist, Include, Support and Engate (RAISE) Family Caregivers Act: Establishing a national strategy to support family caregivers.
HR 1314 - Bipartisan Budget Act/Budget Control Act relief to end sequestration for non-defense discretionary spending: Funding for AAFP priorities; mitigating budget increases for medicare part B enrollees.
HR 2029 - Funding of primary care and quality research at Agency for Healthcare Research and Quality: Primary care research at AHRQ.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness and advocate for AAFP's policy proposals on GME; advocate for introduction of a bill to help fix a suite of issues predominantly impacting rural health (e.g. rotators problem); advocate for improvement of the VA GME framework to better accommodate family medicine.
No Bill No. - Congressional Primary Care Caucus: primary Care to achieve the triple aim in health care.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: GME for community based family medicine residencies.
No Bill No.-Veterans Health Administration Graduate Medical Education: Federal support for family medicine education and training.
No Bill No. - National Coalition on Health Care forum on Advanced Medication Home: Primary care practice model.
No Bill No. - House primary care caucus: launching the caucus.
No Bill No. - Mental Health Reform: Promoting primary care physicians' role in proving mental health.
No Bill No. - Teaching Health Center Graduate Medical education permanence: maintain the sustainability of the THCGME program.
No Bill No. - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus: Primary care to achieve the triple aim in health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 938, S 1299, S2151 - NHSC provisions in mental health reform. Primary care physician workforce.
HR 3020 - Oppose House draft FY 16 bill to eliminate AHRQ: Primary care practice-based research, patient safety, HIT.: Prevent penalty on FPs who have not met MU2.
HR 3940 - Meaningful Use 2 hardship relief: granting CMS authority to use blanket hardship exemptions for MU2 penalties.
S. 1695, HR 3020, HR 2029 - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
HR 1314 - Bipartisan Budget Act/Budget Control Act relief to end sequestration for non-defense discretionary spending: Funding for AAFP priorities; mitigating budget increases for medicare part B enrollees.
HR 2017 - Common Sense Nutrition disclosure act: Supporting current FDA policy on menu labeling.
HR 2029 - Consolidated appropriations act: Permitting CDC to conduct research on gun violence.
HR 2029 - Funding of primary care and quality research at Agency for Healthcare Research and Quality
HR 2058 FDA Deeming Clarification Act: Opposing the exemption of e-cigarettes and cigars from premarket review by the FDA.
HR 2646 - Helping Families in Mental Health Crisis Act: Integrating Primary Care and mental health.
HR 3242 - Child Nicotine Poisoning Prevention Act: Authorizing consumer product safety commission to require child resistant packaging for liquid nicotine.
HR 3940 Meaningful Use Hardship Relief Act: Granting CMS authority to use blannket hardship exemptions for Meaningful Use stage 2 penalties.
HR 4234 - Primary Care Physician Reentry Act: Support family physicians wishing to re-enter practice.
S. 1719 - Recognize, Assist, Include, Support and Engate (RAISE) Family Caregivers Act: Establishing a national strategy to support family caregivers.
S. 1945 - Mental Health reform Act: Integrating primary Care and mental health.
No Bill No. - Chronic Care Management: advocate for introduction of bill to eliminate the Part B coinsurance.
No Bill No.- Health IT: Lobby to raise awareness of hardships created by implementation of Meaningful Use program; advocate for a pause on Stage 3, etc.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness and advocate for AAFP's policy proposals on GME; advocate for introduction of a bill to help fix a suite of issues predominantly impacting rural health (e.g. rotators problem); advocate for improvement of the VA GME framework to better accommodate family medicine.
No Bill No.- Physician Payment Reform: MACRA implementation questions/conversations.
No Bill No. - Internal Revenue Code: Advocate for US tax law to allow people with HSAs to contract with physicians outside of insurance (which will allow physicians practicing with direct primary care to have more access to patients).
No Bill No. - HHS budget planning for FY 16&17: funding for AAFP priorities.
No Bill No. - Congressional Primary Care Caucus: Primary care to achieve the triple aim in health care; Launching the caucus.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: GME for community based family medicine residencies.
No Bill No. - Meaningful Use 3 implementation pause: Align MU timeline with MACRA advanced payment models.
No Bill No. - Veterans Health Administration Graduate Medical Education: Federal Support of family medicine education and training.
No Bill No. - National Advisory Council on National Health Service Care (NHSC): Primary care physician workforce and medical student debt relief.
No Bill No. - Congressional Public Health Caucus bfg: AAFp Federal Spending priorities.
No Bill No.- HRSA Title VII technical assistance webinars: Primary Care training grants.
No Bill No. - National Coalition on Advanced Medical Home: Primary care practice model.
No Bill No.- AAFP initiative to address opioid abuse: Appropriate pain management preventing opioid abuse.
No Bill No. - Nominate FPs to HHS HIV committee, CDC prevention committee, VA rural Health Committee, HRSA Committee: Getting FPs on federal committees.
No Bill No. - MACRA implementation: Letters regarding MACRA implementation.
No Bill No. - Non-discrimination in health plans: Calling for nondiscrimination in health plans and limited English proficiency requirements.
No Bill No. - Tobacco Control: tobacco cessation benefits.
No Bill No. - FPs ability to treat commercial truck drivers: Ability for PCPs to treat diabetes.
No Bill No. - CMS on GAO RUC report: Calling on CMS to address GAO RUC report on physician payment.
No Bill No. - 2017 Marketplaces: Insurance design in 2017 plans.
No Bill No. - HPV Gardasill vaccine: comments on patient info.
No Bill No. - 2016 final medicare fee schedule: Commented on CMS final policy changes for 2016.
No Bill No. - Advance care planning: Support for advance care planning code.
No Bill No. - Discharge Planning: discharge planning proposed rule.
No Bill No. - Medicaid access: Medicaid access final rule.
No Bill No. - Child-resistant packaging for liquid nicotine: Requiring child-resistant packaging for liquid nicotine.
No Bill No. - Prescription Drug Abuse: Participating in White House forum on Prescription Drug Abuse.
No Bill No. - Medicare Access and CHIP Reauthorization Act MACRA implementation: Responding to CMS RFT on implementation of MACRA payment methods.
No Bill No. - Tobacco cessation clinical recommendations: Requiring comprehensive tobacco cessation benefit.
No Bill No.-Health IT: Working to promote legislation for the FLEX-IT2 Act; and Meaningful Use flexibility; attend weekly coalition meetings.
No Bill No. - Attend weekly legislative strategy meetings: Support of Legislative efforts to advance primary care policies through insurance reform, public health, graduate medical education and regulatory flexibility.
No Bill No. - Legislative strategy: Promoting legislative efforts to advance primary care policies.
No Bill No. - Public health coalition meeting: Advancing the integration of public health and primary care through access to mental health, injury prevention and other policies.
No Bill No. - Attend Adult Vaccine monthly coalition meetings; hearing questions.
No Bill No. - Primary care issues: Meaningful Use, MACRA, Mental Health.
No Bill No. - Mental Health reform; preparing materials, briefing AAFP leaders
, participating in coalition meetings and calls: Promoting primary care physicians' role in improving mental health.
No Bill No. - Mental health/Substance Abuse: Educating policymakers about the AAFP;s views on substance abuse and mental health issues.
No Bill No. - Chronic Care Management: advocate for introduction of bill to eliminate the Part B coinsurance.
No Bill No. - Health Insurance Marketplace Issues and Provider Involvement with Patient Enrollment: Network adequacy, patient enrollment in marketplaces.
No Bill No. - Children's Health Insurance: CHIP Program.
No Bill No. - Health Market Consolidation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Office of Administration, Agency for Healthcare Research & Quality (AHRQ), Health & Human Services - Dept of (HHS), Veterans Affairs - Dept of (VA), Health Resources & Services Administration (HRSA), Labor - Dept of (DOL), Transportation - Dept of (DOT), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 2029 - Funding of primary care and quality research at Agency for Healthcare Research and Quality
HR 2646 - Helping Families in Mental Health Crisis Act: Integrating Primary Care and mental health.
HR 3020 - Oppose House draft FY 16 bill to eliminate AHRQ: Primary care practice-based research, patient safety, HIT.: Prevent penalty on FPs who have not met MU2.
S. 1945 - Mental Health reform Act: Integrating primary Care and mental health.
No Bill No. - Medicare Access and CHIP Reauthorization Act MACRA implementation: Responding to CMS RFT on implementation of MACRA payment methods.
No Bill No.- Chronic Care Management: advocate for introduction of bill to eliminate the Part B coinsurance.
No Bill No.-Health IT: Lobby to raise awareness of hardships created by implementation of Meaningful Use Program; advocate for a pause on stage 3, etc.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness of AAFP's policy proposals on GME; advocate for introduction of a bill that would help fix a whole suite of issues predominantly impacting rural health (e.g. rotators problem); advocate for improvement of the GME framework to better accommodate family medicine.
No Bill No. - Physician payment reform: MACRA implementation questions/conversations.
No Bill No. - HHS Budget and Planning for FY16&17: Funding for AAFP priorities.
No Bill No. - Congressional Primary Care Caucus: Primary care to achieve the triple aim in health care.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: GME for community based family medicine residencies.
No Bill No. - Meaningful Use 3 implementation pause: Align MU timeline with MACRA advanced payment models.
No Bill No. - National Advisory Council on National Health Service Care (NHSC): Primary care physician workforce and medical student debt relief.
No Bill No. - AAFp Initiative to address opioid use: Appropriate pain management preventing opioid abuse.
No Bill No. - Meaningful Use/interoperability roadmap: How to make EHRs work well.
No Bill No. - MACRA Implementation: Letters regarding MACRA implementation.
No Bill No. - Nondiscrimination in health plans: Calling for nondiscrimination in health plans and limited English proficiency requirements.
No Bill No. - CMS on GAO RUC report: calling on CMS to address GAO RUC report on physician payment.
No Bill No. - 2016 final Medicare fee schedule: Commented on CMS final policy changes for 2016.
No Bill No. - Advance Care Planning: Support for advance care planning code.
No Bill No. - discharge Planning: Discharge planning proposed rule.
No Bill No. - Narrow provider networks: Updating Physician network every 30 days.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: GME for community based family medicine residencies.
No Bill No.-Graduate Medical Education: raise awareness of AAFP's policy proposals on GME;
No Bill No. - Congressional Primary Care Caucus: Primary care to achieve the triple aim in health care; Launching the caucus.
No Bill No. - Delay implementation of stage 3 of meaningful use program - health IT: Lobby to raise awareness of hardships created by implementation of Meaningful use program.
No Bill No.: Chronic Care Management: advocate for introduction of bill to eliminate Part B coinsurance.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Office of Administration, Agency for Healthcare Research & Quality (AHRQ), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
HR 2058 - FDA deeming authority clarification act: Opposing the exemption of e-cigarettes and cigars from pre-market review by FDA.
HR 3242 - Child Nicotine Poisoning Prevention Act: Authorizing consumer product safety commission to require child resistant packaging for liquid nicotine.
No Bill No. - Liquid Nicotine Packaging: Recommending FDA require child-proof packaging for liquid nicotine packages.
No Bill No. - Tobacco Cessation clinical recommendations: Requiring comprehensive tobacco cessation benefit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
No Bill No.-Health market consolidation; Health Insurance consolidation, provider consolidation, hospital consolidation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Morey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
No Bill No.-Prescription Drug Abuse: prioritizing prevention of prescription drug abuse.
No Bill No. - Opioid Drug Abuse: Addressing Opioid abuse.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
HR 2029 - Consolidation Appropriations Act: Permitting CDC to conduct research on gun violence.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
HR 3940 - Meaningful Use 2 hardship relief: granting CMS authority to use blanket hardship exemptions for MU2 penalties.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 2017 - Common Sense Nutrition disclosure act: Supporting current FDA policy on menu labeling.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |